TCMBANKIN000044 |
hypericin |
4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone; (component of) Hypericum spp (st. John's wort); Cyclosan; 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro [1,10,9,8-opqra]perylene-7,14-dione P-conformer; NSC 407313; Hypericin & Visible light; NCGC00162454-01; Cyclo werrol; NCI60_006799; VIMRxyn; InChI=1/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,31-36H,1-2H; AIDS052002; Hypericum Extract; Cyclo-Werol; 56690_FLUKA; phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-; HSCI1_000202; C07606; NCGC00163378-01; 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethyl-mesonapthtodianthron; NSC 622946; AIDS000117; AIDS-052002; NSC622946; Hypericum red; Hypericin from Hypericum perforatum; NCI60_003879; DRG-0113; EINECS 208-941-0; 548-04-9; 1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione; LMPK02000026; Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer; BiomolKI_000032; NSC407313; 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione; BiomolKI2_000040; AIDS-000117; Hypericin |
C30H16O8 |
504.44 |
CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O |
TCMBANKIN013402 |
2,6-dihydroxy-4-[(e)-7-hydroxy-3,7-dimethyl-octa-2-enyloxy]benzophenone |
|
C23H28O5 |
|
CC(=CCOC1=CC(=C(C(=C1)O)C(=O)C2=CC=CC=C2)O)CCCC(C)(C)O |
TCMBANKIN015291 |
2- caffeoylquinic acid |
|
|
|
|
TCMBANKIN019459 |
2',6-dihydroxy-4'-meth-oxy-2-arylbenzofuran |
|
|
|
|
TCMBANKIN026098 |
r-(?)-skyrin-6-o-β-d-xylopyranoside |
|
C35H26O14 |
|
|
TCMBANKIN027959 |
1,3-dihydroxy-5-o-β-d-glucopyranosyl-xanthone-4-sulfonate |
|
C19H18O13S |
|
C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)OC4=C(C2=O)C(=CC(=C4S(=O)(=O)O)O)O |
TCMBANKIN034991 |
TCMID |
|
C19H11O6- |
|
CC1=CC(=CC2=CC3=C(C(=C12)[O-])C(=O)C4=C(C=C(C=C4C3=O)O)O)O |
TCMBANKIN036847 |
hyperforin |
(1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione; C07608; Hyperforin; PDSP2_001346; 11079-53-1; (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-1-(2-methyl-1-oxopropyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione; Spectrum5_002025; NCGC00163120-01; hyperforin ; (1R,5R,7S,8R)-4-hydroxy-1-isobutyryl-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-quinone |
C36H54O4 |
551 |
C1(O[H])=C(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C(=O)[C@@]([C@@](C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(C([H])([H])\C([H])=C(/C([H])
([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H])(C(=O)C([H])(C([H])([H])[H])C([H])([H])[H])C(=O)[C@@]12C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H] |
TCMBANKIN042040 |
1,3-Dihydroxy-5-methoxyxanthone-4-sulfonate |
|
|
|
|
TCMBANKIN043751 |
Hyperxanthone |
|
|
310.3 g/mol |
|
TCMBANKIN058130 |
quercetin-3-O-galactoside |
hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside |
C21H19O12- |
463.4 g/mol |
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |